Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders

Clinical Endocrinology

Volumn 80, Issue 3, 2014, Pages 348-355

  Sun, Kan ^a   Lu, Jieli ^a   Jiang, Yiran ^a   Xu, Min ^a   Xu, Yu ^a   Zhang, Jie ^a   Xu, Baihui ^a   Sun, Jichao ^b   Sun, Wanwan ^a   Ren, Chenxi ^a   Liu, Jianmin ^a   Wang, Weiqing ^a   Bi, Yufang ^a   Ning, Guang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPOKALEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; CHINA; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY, ABDOMINAL; POTASSIUM; PREVALENCE;

EID: 84897090395     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12168     Document Type: Article

References (34)

1. Marchesini, G., Bugianesi, E., Forlani, G. et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37, 917-923.
2. Marchesini, G., Brizi, M., Bianchi, G. et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844-1850.
3. Lazo, M. & Clark, J.M. (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Seminars in Liver Disease, 28, 339-350.
4. Norbiato, G., Bevilacqua, M., Meroni, R. et al. (1984) Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein-modified fast and refeeding. European Journal of Clinical Investigation, 14, 414-419.
5. Fallo, F., Della Mea, P., Sonino, N. et al. (2007) Adiponectin and insulin sensitivity in primary aldosteronism. American Journal of Hypertension, 20, 855-861.
6. Zillich, A.J., Garg, J., Basu, S. et al. (2006) Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension, 48, 219-224.
7. Mariosa, L.S., Ribeiro-Filho, F.F., Batista, M.C. et al. (2008) Abdominal obesity is associated with potassium depletion and changes in glucose homeostasis during diuretic therapy. The Journal of Clinical Hypertension (Greenwich), 10, 443-449.
8. Fallo, F., Dalla Pozza, A., Tecchio, M. et al. (2010) Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. American Journal of Hypertension, 23, 2-5.
9. Reungjui, S., Pratipanawatr, T., Johnson, R.J. et al. (2008) Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Current Opinion in Nephrology and Hypertension, 17, 470-476.
10. Polyzos, S.A., Kountouras, J., Zafeiriadou, E. et al. (2011) Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. Journal of the Renin-Angiotensin-Aldosterone System, 12, 498-503.
11. Li, M., Xu, Y., Xu, M. et al. (2012) Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Osteoporotic Fracture in Middle-Aged and Elderly Chinese. Journal of Clinical Endocrinology and Metabolism, 97, 2033-2038.
12. von Elm, E., Altman, D.G., Egger, M. et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet, 370, 1453-1457.
13. Reinert, M., Khaldi, A., Zauner, A. et al. (2000) High level of extracellular potassium and its correlates after severe head injury: relationship to high intracranial pressure. Journal of Neurosurgery, 93, 800-807.
14. Ma, Y.C., Zuo, L., Chen, J.H. et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology, 17, 2937-2944.
15. Zhang, L., Wang, F., Wang, L. et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 379, 815-822.
16. Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
18. Fan, J.G. & Farrell, G.C. (2009) Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology, 50, 204-210.
19. Gu, D., Reynolds, K., Wu, X. et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet, 365, 1398-1405.
20. Cohen, J.C., Horton, J.D. & Hobbs, H.H. (2011) Human fatty liver disease: old questions and new insights. Science, 332, 1519-1523.
21. Day, C.P. & James, O.F. (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology, 114, 842-845.
22. Reungjui, S., Roncal, C.A., Mu, W. et al. (2007) Thiazide diuretics exacerbate fructose-induced metabolic syndrome. Journal of the American Society of Nephrology, 18, 2724-2731.
23. Plavinik, F.L., Rodrigues, C.I., Zanella, M.T. et al. (1992) Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension, 19, II26-II29.
24. Helderman, J.H., Elahi, D., Andersen, D.K. et al. (1983) Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes, 32, 106-111.
25. Unwin, R.J., Luft, F.C. & Shirley, D.G. (2011) Pathophysiology and management of hypokalemia: a clinical perspective. Nature Reviews Nephrology, 7, 75-84.
26. Chatterjee, R., Yeh, H.C., Shafi, T. et al. (2010) Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the Atherosclerosis Risk in Communities (ARIC) study. Archives of Internal Medicine, 170, 1745-1751.
27. Reungjui, S., Hu, H., Mu, W. et al. (2007) Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney International, 72, 1483-1492.
28. Yang, B.C., Li, D.Y., Weng, Y.F. et al. (1998) Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. American Journal of Physiology, 274, H1955-H1961.
29. Nakagawa, T., Sato, W., Glushakova, O. et al. (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. Journal of the American Society of Nephrology, 18, 539-550.
30. Candia, R., Riquelme, A., Baudrand, R. et al. (2012) Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. Liver International, 32, 392-399.
31. Kalupahana, N.S. & Moustaid-Moussa, N. (2012) The reninangiotensin system: a link between obesity, inflammation and insulin resistance. Obesity Reviews, 13, 136-149.
32. Engeli, S., Bohnke, J., Gorzelniak, K. et al. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension, 45, 356-362.
33. Joseph, A.E., Saverymuttu, S.H., al-Sam, S. et al. (1991) Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clinical Radiology, 43, 26-31.
34. Hernaez, R., Lazo, M., Bonekamp, S. et al. (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology, 54, 1082-1090.